142 related articles for article (PubMed ID: 22224244)
1. [Comparative aspects of using neuroprotectors in the management of patients with ischemic stroke].
Ershov VI
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(8 Pt 2):41-4. PubMed ID: 22224244
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy and safety of the combined therapy with citicholine and actovegin in the acute period of ischemic stroke].
Shamalov NA; Stakhovskaia LV; Shetova IM; Efremova NM; Anisimov KV
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(9 Pt 2):13-7. PubMed ID: 21462435
[TBL] [Abstract][Full Text] [Related]
3. [Neuroprotective treatment with citicoline (ceraxon) in patients with ischemic stroke].
Martynov MIu; Boĭko AN; Kamchatnov PR; Kabanov AA; Iasamanova AN; Shchukin IA; Kolesnikova TI; Chubykin VI; Glukhareva AP; Gusev EI
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(3 Pt 2):21-6. PubMed ID: 22677765
[TBL] [Abstract][Full Text] [Related]
4. Edaravone - citicoline comparative study in acute ischemic stroke (ECCS-AIS).
Mitta M; Goel D; Bansal KK; Puri P
J Assoc Physicians India; 2012 Nov; 60():36-8. PubMed ID: 23767201
[TBL] [Abstract][Full Text] [Related]
5. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial.
Heiss WD; Brainin M; Bornstein NM; Tuomilehto J; Hong Z;
Stroke; 2012 Mar; 43(3):630-6. PubMed ID: 22282884
[TBL] [Abstract][Full Text] [Related]
6. [Results of the multicenter prospective study of cerebrolysin safety and efficacy in acute stroke].
Skwortsova VI; Stakhovskaia LV; Shamalov NA; Kerbikov OB
Zh Nevrol Psikhiatr Im S S Korsakova; 2006; Suppl 16():41-5. PubMed ID: 18196634
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective treatment with cerebrolysin in patients with acute stroke: a randomised controlled trial.
Ladurner G; Kalvach P; Moessler H;
J Neural Transm (Vienna); 2005 Mar; 112(3):415-28. PubMed ID: 15583955
[TBL] [Abstract][Full Text] [Related]
8. [Neuroprotection in acute ischemic stroke. Practicability of guidelines for treatment].
Fridman EA; Ottaviano F; Fiol M; Javelier A; Perea JE; Ameriso SF
Rev Neurol; 2001 May 1-15; 32(9):818-21. PubMed ID: 11424030
[TBL] [Abstract][Full Text] [Related]
9. A prospective, randomized, placebo-controlled, double-blind trial about safety and efficacy of combined treatment with alteplase (rt-PA) and Cerebrolysin in acute ischaemic hemispheric stroke.
Lang W; Stadler CH; Poljakovic Z; Fleet D;
Int J Stroke; 2013 Feb; 8(2):95-104. PubMed ID: 23009193
[TBL] [Abstract][Full Text] [Related]
10. [A randomized, double-blind, placebo-controlled study of Cerebrolysin safety and efficacy in the treatment of acute ischemic stroke].
Skvortsova VI; Stakhovskaia LV; Gubskiĭ LV; Shamalov NA; Tikhonova IV; Smychkov AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2004; (Suppl 11):51-5. PubMed ID: 15559222
[TBL] [Abstract][Full Text] [Related]
11. Experience in the use of Actovegin in the treatment of patients with cognitive disorders in the acute period of stroke.
Derev'yannykh EA; Bel'skaya GN; Knoll EA; Krylova LG; Popov DV
Neurosci Behav Physiol; 2008 Oct; 38(8):873-5. PubMed ID: 18802768
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of oral citicoline in acute ischemic stroke: drug surveillance study in 4,191 cases.
Cho HJ; Kim YJ
Methods Find Exp Clin Pharmacol; 2009 Apr; 31(3):171-6. PubMed ID: 19536360
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of Cerebrolysin in early post-stroke recovery: a meta-analysis of nine randomized clinical trials.
Bornstein NM; Guekht A; Vester J; Heiss WD; Gusev E; Hömberg V; Rahlfs VW; Bajenaru O; Popescu BO; Muresanu D
Neurol Sci; 2018 Apr; 39(4):629-640. PubMed ID: 29248999
[TBL] [Abstract][Full Text] [Related]
14. [Influence of neuroprotectors with choline-positive action on the level of brain-injury markers during acute ischemic stroke].
Vaizova OE; Zautner NA; Alifirova VM; Vengerovskiĭ AI
Eksp Klin Farmakol; 2012; 75(3):7-9. PubMed ID: 22679745
[TBL] [Abstract][Full Text] [Related]
15. [Comparative analysis of efficacy of certain neuroprotectors in ischemic stroke].
Skorokhodov AP; Dudina AA; Kolesnikova EA; Koron AE; Kobantsev IuA; Sedova AA
Zh Nevrol Psikhiatr Im S S Korsakova; 2006; Suppl 17():52-6. PubMed ID: 18193579
[TBL] [Abstract][Full Text] [Related]
16. Cerebrolysin and early neurorehabilitation in patients with acute ischemic stroke: a prospective, randomized, placebo-controlled clinical study.
Stan A; Birle C; Blesneag A; Iancu M
J Med Life; 2017; 10(4):216-222. PubMed ID: 29362596
[No Abstract] [Full Text] [Related]
17. [The effect of cerebrolysin in dosage 50 ml on the volume of lesion in ischemic stroke].
Shamalov NA; Stakhovskaia LV; Burenchev DV; Kichuk IV; Tvorogova TV; Botsina AIu; Smychkov AS; Kerbikov OB; Moessler H; Novak P; Skvortsova VI
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12 Pt 2):34-7. PubMed ID: 21626816
[TBL] [Abstract][Full Text] [Related]
18. [The use of citicoline in the acute cerebral stroke].
Shetova IM; Shamalov NA; Botsina AIu
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(12 Suppl 2):51-4. PubMed ID: 20873404
[TBL] [Abstract][Full Text] [Related]
19. Prospective, double blinded, comparative assessment of the pharmacological activity of Cerebrolysin and distinct peptide preparations for the treatment of embolic stroke.
Zhang L; Chopp M; Wang C; Zhang Y; Lu M; Zhang T; Zhang ZG
J Neurol Sci; 2019 Mar; 398():22-26. PubMed ID: 30665068
[TBL] [Abstract][Full Text] [Related]
20. [The active neuroprotective therapy of acute carotid ischemic stroke of moderate severity].
Kukhtevich II; Aleshina NI; Levashova OA
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(12 Pt 2):38-42. PubMed ID: 25726801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
